DermTech, Inc. (DMTKQ) vs Inotiv, Inc. (NOTVQ)

DermTech, Inc. and Inotiv, Inc. are both Diagnostics & Research companies. DermTech, Inc. is the larger, with a market value of $3.3M against $2.8M — 1.2× the size. DermTech, Inc. grew revenue faster over the last twelve months: 9.71% against 5.61%. Inotiv, Inc. has the higher net margin (−17.1% vs −572.2%) and the higher return on invested capital (−6.19% vs −5,493.5%). Across the 17 metrics below, Inotiv, Inc. leads on 9 and DermTech, Inc. on 8.

Valuation

Metric DMTKQ NOTVQ Diagnostics & Research median
P/E n/m n/m 33.95
P/S n/m 0.00 4.87
P/B n/m 0.00 3.12
Price to free cash flow n/m n/m 34.02
EV/EBITDA 0.45 60.99 25.20
EV/Sales (2.49) 1.57 5.66
Earnings yield 0.00% (25,300.00%) (1.75%)
Free cash flow yield 0.00% (2,858.05%) (0.13%)

Profitability

Metric DMTKQ NOTVQ Diagnostics & Research median
Gross margin 8.51% 22.94% 50.89%
Operating margin (588.62%) (9.48%) (8.57%)
Net margin (572.19%) (17.14%) (6.37%)
Free cash flow margin (460.10%) (1.95%) 0.00%
Return on equity (121.75%) (74.09%) (2.92%)
Return on assets (64.00%) (11.85%) (6.71%)
Return on invested capital (5,493.45%) (6.19%) 0.00%

Growth

Metric DMTKQ NOTVQ Diagnostics & Research median
Revenue growth (TTM) 9.71% 5.61% 7.69%
EPS growth (last fiscal year) 20.36% 49.64% —
Revenue growth, 5-year CAGR 44.33% 53.36% 7.40%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric DMTKQ NOTVQ Diagnostics & Research median
Debt to equity 0.00 5.49 0.11
Current ratio 3.53 0.27 2.02
Net debt to EBITDA 0.57 12.68 0.78

Dividend

Metric DMTKQ NOTVQ Diagnostics & Research median
Dividend yield — — 0.70%
Payout ratio 0.00 0.00 0.00

Size

Metric DMTKQ NOTVQ Diagnostics & Research median
Market cap 3.29m 2.79m 2.56b

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack